New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Genco Shipping & Trading Limited (NYSE:GNK), LeapFrog Enterprises, Inc (NYSE:LF), CytRx Corporation (NASDAQ:CYTR), Quiksilver, Inc (NYSE:ZQK)
Genco Shipping & Trading Limited (NYSE:GNK) showed a volume of 2.40 million shares by the end of last trade whereas the average volume of the stock remained 2.05million shares. The stock opened the session at $2.72 but then moved to $2.62. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers,
Is GNK a Solid Investment at These Levels? Read This Report For Details
LeapFrog Enterprises, Inc (NYSE:LF) opened the session at $7.81 and closed the session at $7.92. The stock showed a positive performance of 1.28% in previous trading session. Traded with volume of 2.35 million shares in the prior session and the average volume of the stock remained 1.64 million shares. LeapFrog Enterprises, Inc. (LeapFrog) is a developer of educational entertainment for children. The Company’s product portfolio consists of multimedia learning platforms and related content and learning toys. The Company has developed a number of learning platforms,
For How Long LF will fight for Profitability? Read This Trend Analysis report
CytRx Corporation (NASDAQ:CYTR) opened the session at $7.02 and closed the session at $6.97. The stock showed a positive performance of 0.87% in previous trading session. Traded with volume of 2.33 million shares in the prior session and the average volume of the stock remained 6.18 million shares. The beta of the stock remained 1.33. CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology. The Company's oncology pipeline includes three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib.
Why Should Investors Buy CYTR After The Recent Gain? Just Go Here and Find Out
Quiksilver, Inc (NYSE:ZQK) the stock decreased -2.41% and finished the session at $0.0012. Traded with volume of 2.30 million shares in the prior session and the average volume of the stock remained 1.58 million shares. The beta of the stock remained 2.74. Quiksilver, Inc. is a diversified company that designs, develops and distributes branded apparel, footwear, accessories and related products, catering to the casual, youth lifestyle associated with the sports of surfing, skateboarding and snowboarding.
Will ZQK Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)